TRCT
HGEN

Tower Research Capital (TRC)’s HUMANIGEN, INC. HGEN Stock Holding History

Tower Research Capital (TRC)’s Portfolio HGEN Stock Details HGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-46,289
Closed -$7.04K – 6465
2023
Q2 		$7.04K Sell
46,289
-6,637
-13% -$1.03K ﹤0.01% 4631
2023
Q1 		$8K Buy
52,926
+33,649
+175% +$5.38K ﹤0.01% 4699
2022
Q4 		$2K Sell
19,277
-2,459
-11% -$355 ﹤0.01% 5490
2022
Q3 		$4K Buy
21,736
+12,368
+132% +$6.66K ﹤0.01% 5326
2022
Q2 		$16K Buy
9,368
+5,720
+157% +$12.8K ﹤0.01% 4040
2022
Q1 		$11K Sell
3,648
-8,564
-70% -$22.9K ﹤0.01% 4244
2021
Q4 		$46K Sell
12,212
-16,200
-57% -$94.8K ﹤0.01% 2832
2021
Q3 		$168K Buy
28,412
+25,800
+988% +$362K ﹤0.01% 1974
2021
Q2 		$45K Buy
2,612
+2,376
+1,007% +$43.3K ﹤0.01% 3114
2021
Q1 		$5K Sell
236
-1,762
-88% -$32.2K ﹤0.01% 4724
2020
Q4 		$35K Buy
+1,998
New +$23.9K ﹤0.01% 3460

Other funds holding HGEN

TCM
Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Tower Research Capital (TRC)'s HGEN Position: Q3 2023 in Review

Tower Research Capital (TRC) sold out of HUMANIGEN, INC. (HGEN) in Q3 2023, closing a stake of 46,289 shares — an estimated $7.04K sold.

Tower Research Capital (TRC) first reported a position in HGEN in Q4 2020 and held it in 11 quarters. The position peaked at $168K in Q3 2021. 3 funds tracked by Wall St. Rank hold HGEN as of Q3 2023.

  • Tower Research Capital (TRC) reported no remaining HUMANIGEN, INC. position as of Q3 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 46,289 HUMANIGEN, INC. shares in Q3 2023, an estimated $7.04K.
  • Tower Research Capital (TRC) first reported a position in HUMANIGEN, INC. in Q4 2020 and held it in 11 quarters.
  • Tower Research Capital (TRC)'s HUMANIGEN, INC. position peaked at $168K in Q3 2021.
  • 3 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2023, filed 14 Nov 2023.